These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 7485581)
1. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Lasley RD; Konyn PJ; Hegge JO; Mentzer RM Am J Physiol; 1995 Oct; 269(4 Pt 2):H1460-6. PubMed ID: 7485581 [TBL] [Abstract][Full Text] [Related]
2. Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size. Martin BJ; McClanahan TB; Van Wylen DG; Gallagher KP Basic Res Cardiol; 1997 Aug; 92(4):240-51. PubMed ID: 9342431 [TBL] [Abstract][Full Text] [Related]
3. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Harrison GJ; Willis RJ; Headrick JP Cardiovasc Res; 1998 Oct; 40(1):74-87. PubMed ID: 9876319 [TBL] [Abstract][Full Text] [Related]
4. Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs. Mei DA; Nithipatikom K; Lasley RD; Gross GJ J Mol Cell Cardiol; 1998 Jun; 30(6):1225-36. PubMed ID: 9689596 [TBL] [Abstract][Full Text] [Related]
5. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Mizumura T; Nithipatikom K; Gross GJ Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671 [TBL] [Abstract][Full Text] [Related]
6. Purine metabolite accumulation during myocardial ischemia: adenosine pretreatment versus brief ischemia. Manthei SA; Van Wylen DG Basic Res Cardiol; 1997 Dec; 92(6):368-77. PubMed ID: 9464860 [TBL] [Abstract][Full Text] [Related]
7. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Van Wylen DG Circulation; 1994 May; 89(5):2283-9. PubMed ID: 8181154 [TBL] [Abstract][Full Text] [Related]
8. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning. Miura T; Suzuki K; Shimamoto K; Iimura O Basic Res Cardiol; 1996; 91(6):425-32. PubMed ID: 8996627 [TBL] [Abstract][Full Text] [Related]
9. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury. Lott FD; Guo P; Toombs CF Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632 [TBL] [Abstract][Full Text] [Related]
10. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. Li Y; Kloner RA Circulation; 1993 May; 87(5):1642-8. PubMed ID: 8491020 [TBL] [Abstract][Full Text] [Related]
11. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism. Zhao ZQ; Williams MW; Sato H; Hudspeth DA; McGee DS; Vinten-Johansen J; Van Wylen DG Cardiovasc Res; 1995 Apr; 29(4):495-505. PubMed ID: 7796443 [TBL] [Abstract][Full Text] [Related]
12. [Protection of rat heart myocardium with a selective Na(+)/H(+) exchange inhibitor and ischemic preconditioning]. Pisarenko OI; Studneva IM; Serebriakova LI; Tskitishvili OV; Timoshin AA Kardiologiia; 2005; 45(2):37-44. PubMed ID: 15798704 [TBL] [Abstract][Full Text] [Related]
13. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition. Manthei SA; Reiling CM; Van Wylen DG Cardiovasc Res; 1998 Jan; 37(1):171-8. PubMed ID: 9539871 [TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Silva PH; Dillon D; Van Wylen DG Cardiovasc Res; 1995 May; 29(5):616-23. PubMed ID: 7606748 [TBL] [Abstract][Full Text] [Related]
15. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart. McCully JD; Uematsu M; Parker RA; Levitsky S J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910 [TBL] [Abstract][Full Text] [Related]
16. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911 [TBL] [Abstract][Full Text] [Related]
18. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts. Hoshida S; Kuzuya T; Nishida M; Yamashita N; Oe H; Hori M; Kamada T; Tada M Cardiovasc Res; 1994 Jul; 28(7):1083-8. PubMed ID: 7954595 [TBL] [Abstract][Full Text] [Related]
19. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. Headrick JP J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064 [TBL] [Abstract][Full Text] [Related]
20. Remote ischemic preconditioning impairs ventricular function and increases infarct size after prolonged ischemia in the isolated neonatal rabbit heart. Schmidt MR; Støttrup NB; Michelsen MM; Contractor H; Sørensen KE; Kharbanda RK; Redington AN; Bøtker HE J Thorac Cardiovasc Surg; 2014 Mar; 147(3):1049-55. PubMed ID: 23871143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]